文献速递自身免疫性与大疱性皮肤病

IL-34促进天疱疮皮损中产生IL-1β的髓系细胞炎症作用

Interleukin (IL)-34 promotes the inflammatory role of IL-1β-producing myeloid cells in pemphigus lesions.
PubMed 文献 · Br J Dermatol · 2025-01-01

本研究通过单细胞RNA测序发现,天疱疮皮损中产生IL-1β的巨噬细胞(IL1B_Macro)是优势髓系亚群,具有强炎症和趋化转录特征。IL-34与TNF-α协同促进该细胞分化,且可被CSF-1R抑制剂减弱。角质形成细胞是高IL-34的主要来源,提示IL-34/CSF-1R通路为潜在治疗靶点。

要点

  • 天疱疮皮损中IL1B_Macro来源于经典单核细胞,高表达IL-1β、IL-6及CCL20等趋化因子。
  • IL-34与TNF-α协同增强IL1B_Macro分化,CSF-1R抑制剂可减弱此效应。
  • 角质形成细胞是高IL-34主要来源,IL-34/CSF-1R通路为潜在治疗靶点。

核心结论

  • 产生IL-1β的髓系细胞通过炎症和趋化途径在天疱疮皮损ELS形成中起关键作用。
  • 角质形成细胞产生IL-34驱动局部炎症,IL-34/CSF-1R通路为潜在治疗靶点。

研究设计与样本

  • 采用单细胞RNA测序鉴定天疱疮皮损中的髓系亚群并研究其功能。
  • 用免疫组化、免疫荧光和流式细胞术验证产生IL-1β的髓系细胞。
  • 通过培养、bulk RNA-seq和transwell趋化实验评估IL-34和TNF-α对单核细胞的作用。

主要发现

  • 天疱疮皮损ELS中富含髓系细胞,包括寻常型天疱疮和落叶型天疱疮。
  • IL1B_Macro是皮损中优势髓系亚群,起源于经典单核细胞,高表达IL-1β、IL-6及CCL20、CCL3、CCL5、CXCL5等趋化因子。
  • IL-34和TNF-α协同增强IL1B_Macro分化,可被CSF-1R抑制剂减弱;IL-34单独也促进IL-1β和CCL20表达。
  • 角质形成细胞是天疱疮皮损中IL-34升高的主要来源。
  • Bulk RNA-seq显示角质形成细胞高IL-34表达与CCL5、IL-6和IL-23α水平升高相关。

关键数值与推荐

  • IL1B_Macro高表达IL-1β、IL-6及CCL20、CCL3、CCL5、CXCL5。
  • IL-34与TNF-α协同增强IL1B_Macro分化,CSF-1R抑制剂可减弱该效应。
  • 角质形成细胞高IL-34表达与CCL5、IL-6和IL-23α水平升高相关。

临床怎么用

  • 检测天疱疮皮损中IL1B_Macro和IL-34表达可能有助于评估局部炎症状态。
  • IL-34/CSF-1R通路可作为天疱疮潜在治疗靶点,CSF-1R抑制剂可能减弱IL1B_Macro分化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pemphigus is a life-threatening autoimmune disease mediated by anti-desmoglein (Dsg) autoantibodies. Ectopic lymphoid-like structures (ELS) are frequently found in chronic skin lesions and are thought to contribute to local autoantibody production. However, the mechanisms driving ELS formation at lesion sites remain unclear. OBJECTIVES: To investigate the role of myeloid cells in the formation of ELS in pemphigus lesions, and to identify potential therapeutic targets by better understanding the underlying mechanisms that contribute to this process. METHODS: We used single-cell RNA sequencing (scRNA-seq) to identify the myeloid subpopulations in pemphigus lesions and study their functions. Immunohistochemistry (IHC), immunofluorescence and flow cytometry were used to validate the presence of interleukin (IL)-1β-producing myeloid cells. Culture, bulk RNA-seq and transwell chemotaxis experiments were conducted to assess the effects of IL-34 and tumour necrosis factor (TNF)-α on monocytes. Additionally, the high expression of IL-34 in pemphigus keratinocytes was validated by IHC. RESULTS: We first confirmed the abundant presence of myeloid cells within ELS in pemphigus skin lesions, including pemphigus vulgaris and pemphigus foliaceus. Single-cell RNA-seq revealed that IL-1β-producing macrophages ('IL1B_Macro') is the dominant myeloid subpopulation in pemphigus lesions, originating from classical monocytes. These cells have a strong inflammatory and chemotactic transcriptomic profile, expressing high levels of IL-1β, IL-6 and chemokines such as CCL20, CCL3, CCL5 and CXCL5, promoting leucocyte infiltration. Ex vivo experiments showed that IL1B_Macro differentiation is enhanced by the synergistic action of IL-34 and TNF-α, which can be attenuated by a colony-stimulating factor 1 receptor (CSF-1R) inhibitor. IL-34 alone also promotes IL-1β and CCL20 expression, and keratinocytes were found to be the major source of elevated IL-34 in pemphigus lesions. Bulk RNA-seq data indicated that high IL-34 expression in pemphigus keratinocytes correlates with increased levels of CCL5, IL-6 and IL-23α. CONCLUSIONS: IL-1β-producing myeloid cells play a crucial role in the formation of ELS in pemphigus lesions through inflammatory and chemotactic pathways. Keratinocytes contribute to this process by producing IL-34, which fuels local inflammation. These findings offer new insights into pemphigus immunopathogenesis and suggest the IL-34/CSF-1R pathway as a potential therapeutic target. Pemphigus (pronounced ‘pem-fi-gus’) is a severe autoimmune skin disease. In pemphigus, the immune system produces antibodies that attack proteins on a type of skin cell called ‘keratinocytes’. This causes painful blisters and sores on the skin. In this study, we looked at the processes in cells that can play a role in the development of pemphigus. We found that a specific type of immune cell invades pemphigus lesions and helps form structures called ‘ELS’. ELS produce harmful antibodies. ELS stands for ‘ectopic lymphoid-like structures’. We carried out a series of experiments to try and confirm the presence of these specific immune cells. We also found that other immune cells contribute to the development of ELS. By stopping ELS forming, inflammation in the body could be reduced. This might be an option for treating pemphigus. We also found that keratinocytes produce high levels of a protein called ‘IL-34’. This indicates that keratinocytes have an active role in the inflammation seen in pemphigus. Our findings provide new insights that could contribute to the development of future treatments for people living with pemphigus.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Huang Z, Zhao W, Xu C, et al. Interleukin (IL)-34 promotes the inflammatory role of IL-1β-producing myeloid cells in pemphigus lesions. Br J Dermatol. 2025. PMID: 40203120. doi:10.1093/bjd/ljaf130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。